))
Ep.5 Management of early Triple Negative Breast Cancer
Fetch error
Hmmm there seems to be a problem fetching this series right now.
Last successful fetch was on January 27, 2024 09:12 (
What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.
Manage episode 391443697 series 3540536
Content provided by Prashant Jambunathan. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Prashant Jambunathan or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
In this episode, we will talk about the introduction of platinum compounds and immunotherapy in the management of early triple negative breast cancer with a view of improve pathological complete response rates. The discussion will include analysis of the GeparSixto, Brightness, Keynote 522, GeparNeuvo, Create-X and SYSUCC trials. We will also delve into the pivotal study by Tata Memorial Hospital, Mumbai, in this space to further our understanding in the management of this challenging histology.
22 episodes
Share
